All News #Library
Biotech
Vico Initiates VO659 Dosing in Huntington`s, SCA3 & SCA1 Patients
24 Feb 2026 //
PHARMIWEB
Vico Therapeutics Announces Positive VO659 Data In Huntington`s Disease
13 Sep 2024 //
PR NEWSWIRE
Vico Announces First Patient Dosed in Phase 1/2a Clinical Trial of VO659
03 Apr 2023 //
PR NEWSWIRE

Market Place
Sourcing Support